Senores Pharmaceuticals Limited
Senores Pharmaceuticals Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: SENORES and BSE: 544319 (ISIN INE0RB801010).
It has a market capitalisation of ₹5,773 crore, a last close of ₹1,254 on 2026-10-19, a one-year return of 75.4%.
Valuation: a price-to-earnings ratio of 60.92x, a price-to-book ratio of 6.18x, a dividend yield of 0.0%.
Profitability: return on equity of 0.0%, return on capital employed of 17.0%, an operating margin of 29.6%.
Balance sheet and ownership: debt-to-equity of 0.35x, promoter holding of 45.8%.
| Metric | Value |
|---|---|
| Market capitalisation | 5,773 |
| Last close | ₹1,254 |
| P/E (TTM) | 60.92x |
| P/B | 6.18x |
| Dividend yield | 0.0% |
| ROE (FY) | 0.0% |
| ROCE (FY) | 17.0% |
| Operating margin (TTM) | 29.6% |
| Debt / equity | 0.35x |
| Promoter holding | 45.8% |
| 1-year return | 75.4% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means